European-funded consortium brings together researchers from 13 countries to evaluate bacteriophage therapy as a potential alternative to antibiotics for recurrent urinary tract infections.
European-funded consortium brings together researchers from 13 countries to evaluate bacteriophage therapy as a potential alternative to antibiotics for recurrent urinary tract infections.